These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 25117182)

  • 41. Soluble receptor-binding cancer antigen expressed on SiSo cells in pleural fluid: a potential diagnostic marker for malignant pleural effusion.
    Aoe K; Hiraki A; Maeda T; Murakami T; Yamazaki K; Sugi K; Takeyama H
    Chest; 2004 Oct; 126(4):1195-7. PubMed ID: 15486382
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of two strategies for the interpretation of tumour markers in pleural effusions.
    Trapé J; Sant F; Franquesa J; Montesinos J; Arnau A; Sala M; Bernadich O; Martín E; Perich D; Pérez C; Lopez J; Ros S; Esteve E; Pérez R; Aligué J; Gurt G; Catot S; Domenech M; Bosch J; Badal JM; Bonet M; Molina R; Ordeig J
    Respir Res; 2017 May; 18(1):103. PubMed ID: 28545517
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differences in
    Xie T; Wang Q; Gao J; He K; Yu J
    Ann Clin Lab Sci; 2024 Mar; 54(2):201-210. PubMed ID: 38802158
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pleural cancer antigen-125 levels in benign and malignant pleural effusions.
    Choi WI; Qama D; Lee MY; Kwon KY
    Int J Tuberc Lung Dis; 2013 May; 17(5):693-7. PubMed ID: 23575338
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic and prognostic significance of survivin levels in malignant pleural effusion.
    Görgün D; Seçik F; Midilli K; Akkaya V; Yıldız P
    Respir Med; 2013 Aug; 107(8):1260-5. PubMed ID: 23791464
    [TBL] [Abstract][Full Text] [Related]  

  • 46. LC-MS-based serum metabolic profiling for genitourinary cancer classification and cancer type-specific biomarker discovery.
    Lin L; Huang Z; Gao Y; Chen Y; Hang W; Xing J; Yan X
    Proteomics; 2012 Aug; 12(14):2238-46. PubMed ID: 22685041
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pentraxin-3: A novel biomarker for discriminating parapneumonic from other exudative effusions.
    Ozsu S; Abul Y; Mentese A; Bektas H; Uzun A; Ozlu T; Porcel JM
    Respirology; 2013 May; 18(4):657-62. PubMed ID: 23286371
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum metabolic profiling study of lung cancer using ultra high performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
    Li Y; Song X; Zhao X; Zou L; Xu G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():147-53. PubMed ID: 24856296
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vascular endothelial growth factor in pleural fluid for differential diagnosis of benign and malignant origin and its clinical applications.
    Fiorelli A; Vicidomini G; Di Domenico M; Napolitano F; Messina G; Morgillo F; Ciardiello F; Santini M
    Interact Cardiovasc Thorac Surg; 2011 Mar; 12(3):420-4. PubMed ID: 21172937
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Performance of CEA and CA19-9 in identifying pleural effusions caused by specific malignancies.
    Hackbarth JS; Murata K; Reilly WM; Algeciras-Schimnich A
    Clin Biochem; 2010 Sep; 43(13-14):1051-5. PubMed ID: 20529669
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolomic Profiling of Plasma from Patients with Tuberculosis by Use of Untargeted Mass Spectrometry Reveals Novel Biomarkers for Diagnosis.
    Lau SK; Lee KC; Curreem SO; Chow WN; To KK; Hung IF; Ho DT; Sridhar S; Li IW; Ding VS; Koo EW; Wong CF; Tam S; Lam CW; Yuen KY; Woo PC
    J Clin Microbiol; 2015 Dec; 53(12):3750-9. PubMed ID: 26378277
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reactive oxygen species modulator 1 (Romo1) as a novel diagnostic marker for lung cancer-related malignant effusion.
    Lee SH; Park MJ; Choi SI; Lee EJ; Lee SY; In KH
    Medicine (Baltimore); 2017 Jan; 96(4):e5975. PubMed ID: 28121949
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Simultaneous detection of 10 cancer-associated amino acids and polyamines by high-performance liquid chromatography-high resolution mass spectrometry in pleural effusion cells obtained from lung adenocarcinoma patients.
    Wang T; Pan Y; Hu X; Ren W; Li L; Huang J
    J Pharm Biomed Anal; 2024 Dec; 251():116418. PubMed ID: 39180893
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Diagnostic value of DNA, RNA and proliferating cell nuclear antigen examination in malignant pleural effusions by flow cytometry].
    Wang LX; Chen WX; Wu J; Chen SX; Huang XY; Chen YF
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Dec; 29(12):804-7. PubMed ID: 17327081
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The diagnostic significance of the detection of cytokeratin 19 mRNA by quantitative RT-PCR in benign and malignant pleural effusions.
    Xu F; Chen J; Shen HH; Wang XD; Shan J
    J Zhejiang Univ Sci; 2004 Oct; 5(10):1286-9. PubMed ID: 15362202
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunocytochemistry and ELISA quantitation of mucin for diagnosis of malignant pleural effusions.
    Yang PC; Luh KT; Kuo SH; Wu CW
    Am Rev Respir Dis; 1992 Dec; 146(6):1571-5. PubMed ID: 1456577
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pressurized CEC coupled with QTOF-MS for urinary metabolomics.
    Wu Q; Yu X; Wang Y; Gu X; Ma X; Lv W; Chen Z; Yan C
    Electrophoresis; 2014 Sep; 35(17):2470-8. PubMed ID: 24789083
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
    Klech H; Rona G; Hutter C; Bayer PM; Kummer F
    Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Th1 and Th2 cytokine profiles in malignant pleural effusion.
    Ghayumi MA; Mojtahedi Z; Fattahi MJ
    Iran J Immunol; 2011 Dec; 8(4):195-200. PubMed ID: 22201616
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differentiating tuberculous from malignant pleural effusions: a scoring model.
    Porcel JM; Vives M
    Med Sci Monit; 2003 May; 9(5):CR175-80. PubMed ID: 12761453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.